- Intendis, Inc. products are available only by prescription from a licensed HealthCare professional. Intendis, Inc. is not engaged in rendering medical advice or service.
- You may browse this Site. You may print material from the Site. Any and all downloaded materials may be used by you for personal, non-commercial use. You may not use in any manner any of such materials for public or commercial purposes, without the express written permission of Intendis, Inc. All copyright and other proprietary notices contained in downloaded materials from the web site must be retained.
- All product names, logos and service marks displayed on the Site that are identified by ® or ™ or appearing in type form different from that of the surrounding text (collectively, the "Trademarks") are registered or unregistered Trademarks owned by or licensed to Intendis, Inc. or our affiliates, unless otherwise identified as being owned by another entity. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right, either express or implied, under any patent or Trademark of Intendis, Inc. or any third party. No use of any Trademark may be made without the prior written authorization of Intendis, Inc., except to identify the product or services of the company.
- You should assume that all contents of the web site are copyrighted unless otherwise noted and may not be used except as provided herein and without the express written permission of Intendis, Inc. Except as expressly provided above, nothing contained herein shall be construed as conferring any license or right under any Intendis, Inc. copyright.
- You are prohibited from posting or transmitting to the web site any unlawful, threatening, libelous, defamatory, obscene, inflammatory, pornographic or profane material or any material that could constitute or encourage conduct that would be considered a criminal offense, give rise to civil liability or would otherwise violate the law. Intendis, Inc. will fully cooperate with any law enforcement authorities or court order requesting or directing Intendis, Inc. to disclose the identity of anyone posting any such information or materials.
Disclaimer
INTENDIS, INC. MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND OR NATURE WITH RESPECT TO ANY OF THE INFORMATION CONTAINED ON THIS SITE. INTENDIS, INC. HealthCare PHARMACEUTICALS DISCLAIMS ALL REPRESENTATIONS AND/OR WARRANTIES, EXPRESS OR IMPLIED, CREATED BY LAW, CONTRACT OR OTHERWISE, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE OR NONINFRINGEMENT.
In no event shall Intendis, Inc. be liable for any damages of any kind or nature, including without limitation, direct, indirect, special, consequential or incidental damages arising from or in connection with the existence or use of the Internet site and/or the information.
Finacea is indicated for topical treatment of inflammatory papules and pustules of mild to moderate rosacea. Although some reduction of erythema which was present in patients with papules and pustules of rosacea occurred in clinical studies, efficacy for treatment of erythema in rosacea in the absence of papules and pustules has not been evaluated.
Finacea is for dermatologic use only, and not for ophthalmic, oral, or intravaginal use. Finacea is contraindicated in individuals with a history of hypersensitivity to propylene glycol or any other component of the formulation. In clinical trials, sensations of burning/stinging/tingling occurred in 29% of patients, and itching in 11%, regardless of the relationship to therapy. Post-marketing safety—Skin: facial burning and irritation; Eyes: iridocyclitis on accidental exposure to the eye. There have been isolated reports of hypopigmentation after use of azelaic acid. Since azelaic acid has not been well studied in patients with dark complexion, these patients should be monitored for early signs of hypopigmentation.
Images are for illustrative purposes only.